Low-carbohydrate diet and oxidative stress in diabetic and nondiabetic rats

Journal of Biochemical and Molecular Toxicology

Volumn 20, Issue 5, 2006, Pages 259-269

  Kamuren, Zipporah T ^a   Sanders, Ruth ^b   Watkins III, John B ^b  

^a MOI UNIVERSITY   (Kenya)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbohydrate; Diabetes; Heart; Kidney; Liver; Oxidative Stress; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE; CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN A1C; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART; HYPERGLYCEMIA; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RAT STRAIN;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIET, CARBOHYDRATE-RESTRICTED; FEMALE; KIDNEY; LIVER; MALE; MYOCARDIUM; ORGAN SIZE; ORGAN SPECIFICITY; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 33750032933     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20142     Document Type: Article

References (66)

1. Sano T, Umeda F, Hashimoto T, Nawata H, Utsumi H. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia 1998;41:1355-1360.
2. Wohaieb SA, Godin DV. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987;36:1014-1018.
3. Nishikawa T, Edelstein D, Brownlee M. The missing link: A single unifying mechanism for diabetic complications. Kidney Int Suppl 2000;77:S26-S30.
4. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 2002;5:561-568.
5. Hamada Y, Araki N, Horiuchi S, Hotta N. Role of polyol pathway in nonenzymatic glycation. Nephrol Dial Transplant 1996;11:95-98.
6. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 1988;256:205-212.
7. Stitt AW, Jenkins AJ, Cooper ME. Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 2002;11:1205-1223.
8. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998;47:859-866.
9. Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: Role of vascular NAD(P)H oxidase. J Am Soc Nephrol 2003;14:S227-S232.
10. Giannerini F, Giustarini D, Lusini L, Rossi R, Di Simplicio P. Responses of thiols to an oxidant challenge: Differences between blood and tissues in the rat. Chem Biol Interact 2001;134:73-85.
11. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002;288:2579-2588.
12. Maritim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2003;17:24-38.
13. Parillo M, Rivellese AA, Ciardullo AV, Capaldo B, Giacco A, Genovese S, Riccardi G. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism 1992;41:1373-1378.
14. Low CC, Grossman EB, Gumbiner B. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. Diabetes 1996;45:569-575.
15. Julius U. Fat modification in the diabetes diet. Exp Clin Endocrinol Diabetes 2003;111:60-65.
16. Strychar I, Ishac A, Rivard M, Lussier-Cacan S, Beauregard H, Aris-Jilwan N, Radwan F, Yale JF. Impact of a high-monounsaturated-fat diet on lipid profile in subjects with type 1 diabetes. J Am Diet Assoc 2003;103:467-474.
17. Sandelin AC, Sandelin K. Activation of lysosomal enzymes in virus-infected cells and its possible relationship to cytopathic effects. J Exp Med 1963;117:879-887.
18. Chen YD, Coulston AM, Zhou MY, Hollenbeck CB, Reaven GM. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM? Diabetes Care 1995;18:10-16.
19. O'Neill D, Westman EC, Bernstein RK. The effects of a low-carbohydrate regimen on glycemic control and serum lipids in diabetes mellitus. Metab Syndr Relat Disord 2003;1:291-298.
20. Bravata DM, Sanders L, Huang J, Krumholz HM, Olkin I, Gardner CD. Efficacy and safety of low-carbohydrate diets: A systematic review. JAMA 2003;289:1837-1850.
21. National Research Council. Guide for the care and use of laboratory animals. Washington DC: National Academy Press, 1996.
22. Meister A, Tate SS, Griffith OW. Gamma-glutamyl transpeptidase. Methods Enzymol 1981;77:237-253.
23. Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 1975;250:5475-5480.
24. Tappel AL. Glutathione peroxidase and hydroperoxides. Methods Enzymol 1978;52:506-513.
25. Luck H. Catalase. In: Bergmeyer H-U, editor. Methods of enzymatic analysis. New York: Academic Press, 1963. pp 885-888.
26. Crapo JD, McCord JM, Fridovich I. Preparation and assay of superoxide dismutases. Methods Enzymol 1978;53:382-393.
27. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214-226.
28. Lowry O, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with Polin phenol reagent. J Biol Chem 1951;193:265-275.
29. Wolever TM. Dietary carbohydrates and insulin action in humans. Br J Nutr 2000;83(Suppl 1):S97-S102.
30. Campbell LV, Marmot PE, Dyer JA, Borkman M, Storlien LH. The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care 1994;17:177-182.
31. Lerman-Garber I, Ichazo-Cerro S, Zamora-Gonzalez J, Cardoso-Saldana G, Posadas-Romero C. Effect of a high-monounsaturated fat diet enriched with avocado in NIDDM patients. Diabetes Care 1994;17:311-315.
32. Mak DH, Ip SP, Li PC, Poon MK, Ko KM. Alterations in tissue glutathione antioxidant system in streptozotocin-induced diabetic rats. Mol Cell Biochem 1996;162:153-158.
33. Herrman CE, Sanders RA, Klaunig JE, Schwarz LR, Watkins JB III. Decreased apoptosis as a mechanism for hepatomegaly in streptozotocin-induced diabetic rats. Toxicol Sci 1999;50:146-151.
34. Al-Shafei AI, Wise RG, Gresham GA, Bronns G, Carpenter TA, Hall LD, Huang CL. Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J Physiol 2002;538:541-553.
35. Kamiya H, Okumura K, Ito M, Matsui H, Saburi Y, Hayashi K, Hayakawa T. Antioxidant changes in the hypertrophied heart due to energy metabolic disorder. Basic Res Cardiol 2001;96:431-438.
36. Kirshenbaum LA, Singal PK. Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am J Physiol 1993;265:H484-H493.
37. Kirshenbaum LA, Hill M, Singal PK. Endogenous antioxidants in isolated hypertrophied cardiac myocytes and hypoxia-reoxygenation injury. J Mol Cell Cardiol 1995;27:263-272.
38. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996;28:506-514.
39. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Kidney size and glomerular volume. Diabetologia 1979;16:125-128.
40. Rauscher FM, Sanders RA, Watkins JB III. Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2000;14:329-334.
41. Sanders RA, Rauscher FM, Watkins JB III. Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001;15:143-149.
42. Jang YY, Song JH, Shin YK, Man ES, Lee CS. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacol Res 2000;42:361-371.
43. Aragno M, Tamagno E, Gatto V, Brignardello E, Parola S, Danni O, Boccuzzi G. Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radic Biol Med 1999;26:1467-1474.
44. Rauscher FM, Sanders RA, Watkins JB III. Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001;15:159-164.
45. Maritim AC, Moore BH, Sanders RA, Watkins JB III. Effects of melatonin on oxidative stress in streptozotocin-induced diabetic rats. Intl J Toxicol 1999;18:161-166.
46. Abbott WA, Meister A. Intrahepatic transport and utilization of biliary glutathione and its metabolites. Proc Natl Acad Sci USA 1986;83:1246-1250.
47. Kim SK, Woodcraft KJ, Khodadadeh SS, Novak RF. Insulin signaling regulates gamma-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. J Pharmacol Exp Ther 2004;311:99-108.
48. Li S, Li X, Rozanski GJ. Regulation of glutathione in cardiac myocytes. J Mol Cell Cardiol 2003;35:1145-1152.
49. Dincer Y, Akcay T, Alademir Z, Ilkova H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 2002;51:1360-1362.
50. Saxena AK, Srivastava P, Kale RK, Baquer NZ. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 1993;45:539-542.
51. Matkovics B, Kotorman M, Varga IS, Hai DQ, Varga C. Oxidative stress in experimental diabetes induced by streptozotocin. Acta Physiol Hung 1997;85:29-38.
52. Cornwell PD, Watkins JB III. Changes in the kinetic parameters of hepatic gamma-glutamyltransferase from streptozotocin-induced diabetic rats. Biochim Biophys Acta 2001;1545:184-191.
53. Dickinson DA, Forman HJ. Glutathione in defense and signaling: Eessons from a small thiol. Ann NY Acad Sci 2002;973:488-504.
54. Lu SC. Regulation of hepatic glutathione synthesis: Current concepts and controversies. FASEB J 1999;13:1169-1183.
55. Kedziora-Kornatowska KZ, Luciak M, Paszkowski J. Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: Effect of treatment with angiotensin convertase inhibitors. IUBMB Life 2000;49:303-307.
56. Mekinova D, Chorvathova V, Volkovova K, Staruchova M, Grancicova E, Klvanova J, Ondreicka R. Effect of intake of exogenous vitamins C, E and β-carotene on the antioxidative status in kidneys of rats with streptozotocin-induced diabetes. Nahrung 1995;39:257-261.
57. 10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001;15:41-46.
58. Kocak G, Aktan F, Canbolat O, Ozogul C, Elbeg S, Yildizoglu-Ari N, Karasu C. β-Lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab Clin Exp 2000;13:308-318.
59. Kakkar R, Mantha SV, Kalra J, Prasad K. Time course study of oxidative stress in aorta and heart of diabetic rat. Clin Sci 1996;91:441-448.
60. Otsyula M, King MS, Ketcham TG, Sanders RA, Watkins JB III. Oxidative stress in rats after 60 days of hypergalactosemia or hyperglycemia. Int J Toxicol 2003;22:423-427.
61. Ozansoy G, Akin B, Aktan F, Karasu C. Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats. Mol Cell Biochem 2001;216:59-63.
62. Toleikis PM, Godin DV. Alteration of antioxidant status in diabetic rats by chronic exposure to psychological stressors. Pharmacol Biochem Behav 1995;52:355-366.
63. Rauscher FM, Sanders RA, Watkins JB III. Effects of new antioxidant compounds PNU-104067F and PNU-74389G on antioxidant defense in normal and diabetic rats. J Biochem Mol Toxicol 2000;14:189-194.
64. Aliciguzel Y, Ozen I, Asian M, Karayalcin U. Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. J Lab Clin Med 2003;142:172-177.
65. Kaul N, Siveski-Iliskovic N, Thomas TP, Hill M, Khaper N, Singal PK. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition 1995;11:551-554.
66. Zobali F, Avci A, Canbolat O, Karasu C. Effects of vitamin A and insulin on the antioxidative state of diabetic rat heart: A comparison study with combination treatment. Cell Biochem Funct 2002;20:75-80.